Related Experiment Video
Updated: Jul 19, 2026

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse
Published on: July 25, 2011
Neuroprotective effects of safflor yellow B on brain ischemic injury
Chaoyun Wang1, Dalei Zhang, Guisheng Li
1Department of Pharmacology, Xi'an Jiaotong University School of Medicine, Xi'an, Shaanxi 710061, People's Republic of China.
Abstract:
The present study was conducted to investigate whether safflor yellow B (SYB) had a protective effect on cerebral ischemic injury and to determine the possible mechanisms in vivo and in vitro. In vivo, Male Wistar-Kyoto (WKY) rats were used to make the model of middle cerebral artery occlusion (MCAO). The behavioral test was used to measure neurological deficit scores for evaluation of the ischemic damage of brain. The infarction area of brain was assessed in brain slices stained with 2% solution of 2,3,5-triphenyl tetrazolium chloride (TTC). Spectrophotometric assay was used to determine the activities of superoxide dismutase (SOD) and glutathione peroxidase (GPx), contents of malondialdehyde (MDA) and adenosine triphosphate (ATP) of the brain. Furthermore, the respiratory control ratio (RCR = state 3/state 4) was assessed in the brain mitochondria. In vitro, the effect of SYB was tested in cultured fetal cortical cells exposed to glutamate to identify its neuroprotection against neurons damage. The results in vivo showed that SYB at doses of 3.0 and 6.0 mg kg(-1) markedly decreased the neurological deficit scores and the infarction area in MCAO rats. At the same time, SYB significantly improved mitochondrial energy metabolism, decreased MDA content, and increased SOD and GPx activities in ischemic brain. The results in vitro showed that SYB remarkably inhibited neuron damage induced by glutamate in cultured fetal cortical cells. These suggest that SYB might act as a potential neuroprotective agent against the cerebral ischemia-induced injury in rat brain through reducing lipid peroxides, scavenging free radicals, and improving the energy metabolism.
Insights
Safflor yellow B (SYB) shows neuroprotective effects against cerebral ischemic injury. It reduces brain damage, scavenges free radicals, and improves energy metabolism in rats.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Cerebral ischemic injury remains a significant cause of neurological disability.
- Identifying novel therapeutic agents for stroke is crucial.
- Safflor yellow B (SYB) is a compound with potential antioxidant properties.
Purpose of the Study:
- To investigate the neuroprotective effects of SYB on cerebral ischemic injury.
- To elucidate the underlying mechanisms of SYB's action in vivo and in vitro.
- To evaluate SYB's impact on brain damage, neurological deficits, and cellular energy metabolism.
Main Methods:
- In vivo: Middle cerebral artery occlusion (MCAO) model in Wistar-Kyoto rats.
- Assessment of neurological deficit scores, infarct volume, and biochemical markers (SOD, GPx, MDA, ATP).
- In vitro: Glutamate-induced neurotoxicity in cultured fetal cortical cells.
Main Results:
- SYB administration significantly reduced neurological deficits and infarct area in MCAO rats.
- SYB treatment improved mitochondrial energy metabolism (RCR) and antioxidant enzyme activities (SOD, GPx) while decreasing lipid peroxidation (MDA).
- SYB demonstrated significant neuroprotection against glutamate-induced damage in cultured cortical neurons.
Conclusions:
- SYB exhibits potent neuroprotective effects against cerebral ischemia-induced injury.
- The mechanisms involve reducing lipid peroxides, scavenging free radicals, and enhancing brain energy metabolism.
- SYB represents a promising therapeutic candidate for treating stroke and related neurological damage.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
The Blood-brain Barrier